Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gu, Y.
Right arrow Articles by van Oeveren, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, Y.
Right arrow Articles by van Oeveren, W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Blood Thinners
Hazardous Substances DB
*HEPARIN
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical performance of a high-efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinized cardiopulmonary bypass perfusate

YJ Gu

Department of Cardiothoracic Surgery, University Hospital

AJ deVries

Department of Anaesthesiology, University Hospital

PW Boonstra

Department of Cardiothoracic Surgery, University Hospital, Groningen

W. van Oeveren

Department of Cardiothoracic Surgery, University Hospital, Groningen

The method of leucocyte depletion has been recently introduced to the field of cardiopulmonary bypass to reduce leucocyte-mediated organ dysfunction. In this study, we evaluated the efficacy and biocompatibility of the Pall RC400 filters for leucocyte depletion of heparinized cardiopulmonary bypass (CPB) perfusate taken from the heart-lung machine during routine cardiac surgery. For each filter, 700 ml blood were used as filtrate. Filtration was divided into the following groups to study the effect of loading pressure on the efficacy of the filters: under gravity pressure as a control (n = 8), under 100 mmHg (n = 8), 200 mmHg (n = 8), and 300 mmHg loading pressure (n = 8) driven by a roller pump. In addition, heparinized predonation blood taken at the beginning of CPB (n = 8) was filtered under gravity in comparison with the perfusate taken at the end of CPB. The results showed that the average leucocyte removal rate by an RC400 filter for 700 ml of blood was 96.8%. There was no significant difference of leucocyte removal rate between filtration under gravity and under loading pressure up to 300 mmHg. This allows clinical filtration at a speed up to 500 ml/min. The platelet removal rate was significantly higher in blood taken at the beginning of CPB than in blood taken at the end of CPB. Complement split product, C5a, increased only slightly during filtration indicating that this filter, made from polyester, has a good blood compatible characteristic. We conclude that the Pall RC400 leucocyte removal filter is suitable and safe to be used for leucocyte filtration of heparinized CPB perfusate during cardiac surgery.

Perfusion, Vol. 10, No. 6, 425-430 (1995)
DOI: 10.1177/026765919501000606


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PerfusionHome page
M J ten Brinke, P W Weerwind, S Teerenstra, J C. Feron, W van der Meer, and M H. Brouwer
Leukocyte removal efficiency of cell-washed and unwashed whole blood: an in vitro study
Perfusion, December 1, 2005; 20(6): 335 - 341.
[Abstract] [PDF]


Home page
PerfusionHome page
A J de Vries, Y J Gu, and W van Oeveren
Leucocyte filtration of residual heart-lung machine blood in children undergoing congenital heart surgery
Perfusion, December 1, 2004; 19(6): 345 - 349.
[Abstract] [PDF]


Home page
PerfusionHome page
G Matheis, M Scholz, A Simon, O. Dzemali, and A Moritz
Leukocyte filtration in cardiac surgery: a review
Perfusion, September 1, 2001; 16(5): 361 - 370.
[Abstract] [PDF]


Home page
PerfusionHome page
G Matheis, M Scholz, J Gerber, U Abdel-Rahman, G Wimmer-Greinecker, and A Moritz
Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury
Perfusion, January 1, 2001; 16(1): 43 - 49.
[Abstract] [PDF]


Home page
PerfusionHome page
G Matheis, M Scholz, A Simon, D Henrich, G Wimmer-Greinecker, and A Moritz
Timing of leukocyte filtration during cardiopulmonary bypass
Perfusion, January 1, 2001; 16(1_suppl): 31 - 37.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. J. Gu, A.J. de Vries, P. Vos, P. W. Boonstra, and W. van Oeveren
Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit
Ann. Thorac. Surg., March 1, 1999; 67(3): 604 - 609.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren
LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500.
[Abstract] [Full Text]